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Objectives. We sought to determine the prognostic significance
of simultaneous versus independent resolution of ST segment
depression that occurs concomitant with ST segment elevation
during acute myocardial infarction (AMI).
Background. ST segment depression in leads other than those
showing ST segment elevation during AMI is a common phenom-
enon. Whether this indicates adverse outcomes remains contro-
versial. We hypothesized that the timing of ST segment depression
resolution relative to ST segment elevation resolution might
differentiate between a high risk group and a low risk group of
patients.
Methods. Continuous 12-lead ST segment monitoring was
performed after thrombolytic therapy for AMI in 413 patients, 261
of whom met technical criteria for analysis. Blinded analysis of ST
segment depression resolution patterns was used to group pa-
tients as follows: 1) no ST segment depression at any time (control
group); 2) ST segment depression resolving simultaneously with
ST segment elevation (simultaneous group); and 3) ST segment
depression persisting after ST segment elevation resolution (in-
dependent group). These patterns were correlated with the out-
comes—recurrent angina, reinfarction, heart failure and death—
using chi-square analysis and the Fisher exact test for categoric
variables and the Wilcoxon rank-sum test for continuous vari-
ables.
Results. The incidence of recurrent angina, reinfarction and
heart failure was similar among the three groups. In-hospital
mortality, however, was significantly higher in the independent
group (13%) than either the simultaneous group (1%, p < 0.001)
or the control group (0%, p 5 0.002).
Conclusions. Continuous analysis of ST segment resolution
identifies, among patients with AMI with concomitantly occurring
ST segment elevation and depression, a subgroup with increased
in-hospital mortality. The pathogenic mechanism of increased
mortality is not currently known.
(J Am Coll Cardiol 1997;30:1478–83)
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ST segment depression in leads other than those showing ST
segment elevation is a frequently reported phenomenon during
acute myocardial infarction (AMI) (1–3). Whether such ST
segment depression is a marker of adverse clinical outcomes,
as well as the etiology of its occurrence, remains controversial
(1–19). This controversy may exist in part because of consid-
eration of only static electrocardiograms (ECGs), which fail to
differentiate between patients in whom ST segment depression
is an indicator of adverse outcomes and those in whom it is a
benign finding (1–19).
In the setting of coronary occlusion, the spatial vector of ST
segment deviation frequently produces simultaneous ST seg-
ment elevation and depression in the various leads of the
standard ECG. With reperfusion producing resolution of ST
segment elevation, serial ECG assessment illustrates two pat-
terns of ST segment depression resolution: 1) it resolves
simultaneous with ST segment elevation (Fig. 1); and 2) it
persists after ST segment elevation resolution (Fig. 2). Because
the development and resolution of ST segment elevation
have been correlated with infarct-related artery (IRA)
patency (20 –22), the ST segment depression that persists
after the resolution of ST segment elevation might be due to
a process independent of IRA patency. We hypothesized
that these different patterns of ST segment depression might
reflect pathophysiologic processes related to clinical out-
comes.
The purposes of our investigation were to use continuous
12-lead ST segment monitoring to identify distinct patterns
of resolution of ST segment depression relative to resolu-
tion of ST segment elevation and to examine the relation
between these patterns and the incidence of adverse clinical
outcomes in a large, well characterized group of patients
with AMI.
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Methods
Patient group. This study included 413 patients with AMI
who had continuous 12-lead ST segment monitoring initiated
soon after presentation. All these patients were enrolled in
ECG substudies—either the Thrombolysis and Angioplasty in
Myocardial Infarction-9 (TAMI-9) or Global Utilization of
Streptokinase and TPA for Occluded arteries (GUSTO) trial.
These patients presented within 6 h of the onset of chest pain
suggestive of AMI and had ST segment elevation at the time of
presentation. All patients received aspirin and thrombolytic
treatment with adjunctive agents (heparin or Fluosol) accord-
ing to the randomized protocols of TAMI-9 or GUSTO
(23,24). Inclusion and exclusion criteria for enrollment into the
TAMI-9 and GUSTO trials have been previously described in
detail (23,24). For the purpose of our study, patients who had
continuous ST segment monitoring studies with high artifact
content or bundle branch block were excluded (technical
failures, n 5 65). Those patients who did not meet the study
criteria for the resolution of ST segment elevation consistent
with reperfusion were also excluded (n 5 87) because they
could not be risk stratified based on their ST segment resolu-
tion patterns. Thus, 261 patients were included in the final
analysis. All technical grounds for inclusion or exclusion were
determined by investigators who had no knowledge of out-
comes and angiographic data.
Cardiac catheterization. Patients underwent cardiac cath-
eterization according to TAMI-9 or GUSTO protocol after
written informed consent was obtained. The catheterization
data of patients enrolled in TAMI-9 were analyzed at a core
laboratory at the University of Michigan Hospital; the angio-
graphic data of the GUSTO patients were analyzed at the core
laboratory at George Washington University Hospital. The
cardiac catheterization methods for TAMI-9 and GUSTO
have been previously described (23,25). These analyses were
done in blinded manner with regard to ECG and clinical data.
Because a revascularization procedure could potentially affect
the results of angiographic end points, only the results of the
first catheterization (90 min to 7 days after thrombolytic
therapy) during the index hospital period were considered for
our study. Identification of the IRA, determination of the
Thrombolysis in Myocardial Infarction (TIMI) flow grade in
the IRA and number of major coronary arteries with $50%
lumen stenosis and measurement of left ventricular ejection
fraction (LVEF) were all performed by the respective core
laboratories.
Clinical data. All definitions and data for clinical descrip-
tors and outcomes for both TAMI-9 and GUSTO were pro-
vided by the Coordinating Center at Duke University Medical
Center. The clinical data included baseline demographic and
cardiac risk factors. For the purpose of our study, clinical
outcome data for the following variables were analyzed: in-
hospital mortality, reinfarction, recurrent angina and conges-
tive heart failure or pulmonary edema. All outcome variables
were collected by the Coordinating Center, which had no
knowledge of the ST segment monitoring data.
Continuous 12-lead ST segment monitoring. Continuous
12-lead ST segment monitoring was performed using a porta-
ble digital instrument called Eli-ST100 (Mortara Instruments).
This monitor acquires and analyzes a 12-lead median beat
ECG every 20 s, with archival storage at minimal intervals of
20 s and maximal intervals of 20 min, based on the presence or
absence of new or evolving ST segment changes. These digital
ECG data were then transferred to diskettes and analyzed on
a personal computer using the custom software program
previously described (22). Analysis of a continuous 12-lead
ECG using this software program enables the user to follow ST
segment measurements at 60 ms after the J point (J 1 60 ms).
Figure 1. Simultaneous ST segment resolution during AMI. *Point of
ST segment elevation resolution. **Point of ST-segment depression
resolution.
Figure 2. Independent ST segment resolution during AMI. *Point of
ST-segment elevation resolution. **Point of ST-segment depression
resolution.
Abbreviations and Acronyms
AMI 5 acute myocardial infarction
ECG 5 electrocardiogram, electrocardiographic
GUSTO 5 Global Utilization of Streptokinase and TPA for Occluded
Coronary Arteries (trial)
IRA 5 infarct-related artery
LVEF 5 left ventricular ejection fraction
MI 5 myocardial infarction
TAMI-9 5 Thrombolysis and Angioplasty in Myocardial Infarction-9
(trial)
TIMI 5 Thrombolysis in Myocardial Infarction
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Trends for ST segment levels can be followed for resolution or
amplification in all 12 leads or selected leads.
ST segment data analysis. A single observer who had no
knowledge of the clinical and angiographic data analyzed the
ST segment data. All measurements of ST segment deviation
were performed relative to each patient’s own “baseline” ST
segment levels. For the purpose of this study, baseline was
defined as the most normalized ECG (showing the least ST
segment deviation over all 12 leads) at the end of the study.
“Baseline” was ;24 h after thrombolytic therapy, as the
average ST segment monitoring period was 24 h. After estab-
lishing the baseline, continuous 12-lead ST segment data were
analyzed for ST segment deviation patterns relative to the
baseline ECG. “Peak” ST segment elevation and depression
were based on the maximal deviation values in the single lead
with the greatest ST segment elevation and ST segment
depression, respectively. Serial ECGs in the digital monitor
were analyzed until the time of ST segment elevation resolu-
tion. The point of ST segment elevation resolution was defined
when it met both of the following criteria: 1) #50 mV of ST
segment elevation over baseline levels in all leads with ST
segment elevation; and 2) resolution of at least 200 mV or
50%, whichever was greater, from the peak ST segment
elevation. Using these definitions, patients were classified into
three groups based on the presence and resolution character-
istics of ST segment depression: 1) the control group consisted
of patients who did not have ST segment depression of at least
100 mV anytime before the resolution of ST segment eleva-
tion; 2) the simultaneous group consisted of patients who had
ST segment depression of at least 100 mV, which resolved
simultaneously with the resolution of ST segment elevation;
and 3) the independent group consisted of patients in whom
ST segment depression of at least 100 mV persisted in any lead
after ST segment elevation resolution. Those patients who had
persistent ST segment elevation (i.e., did not meet our criteria
for the resolution of ST segment elevation) were excluded
from the final analysis because differentiation between
simultaneous and independent ST segment depression,
based on ST segment resolution patterns, was not possible in
these patients.
Statistical analysis. Data for baseline and clinical outcome
variables are presented as percentages for categoric variables
and 50th (25th, 75th) percentiles for continuous variables. To
determine possible univariate correlates of adverse clinical
outcomes and the ST segment resolution pattern group, we
applied chi-square analysis and the Fisher exact test to cate-
goric variables and the Wilcoxon rank-sum test to continuous
variables. A p value ,0.05 was considered statistically
significant. The 95% confidence intervals were found using
the exact binomial distribution because of the small number
of events in each group. All patients were included in the
final analysis even if the data for some or all of the baseline
characteristics were missing, as long as outcome data were
available.
Results
Baseline demographic, clinical and angiographic variables
for each group are shown in Table 1. The comparison of
adverse prognostic indicators was notable for lower incidences
of diabetes mellitus, hypertension and anterior myocardial
infarction (MI) in the independent group compared with both
the control and simultaneous groups. The LVEF, TIMI flow
grade in the IRA and number of major coronary arteries with
$50% lumen stenosis were not significantly different among
the groups.
Clinical outcomes. In-hospital clinical outcomes are pre-
sented in Table 2. The in-hospital mortality rate was 13% in
the independent group compared with 1% in the simultaneous
group (p , 0.001) and 0% in the control group (p 5 0.002).
The difference between the mortality rates of the control and
simultaneous groups was not significant. The incidences of
recurrent MI, recurrent angina and congestive heart failure
were not significantly different among the groups.
Cause of death. Table 3 shows the cause of death for all six
patients who died during the index hospital period. No deaths
occurred in the control group; two deaths occurred in the
simultaneous group; and four deaths occurred in the indepen-
dent group. Both of the deaths in the simultaneous group were
due to noncardiac causes. All four deaths in the independent
group were cardiac caused. Probably due to the small number
of deaths in the study group, there is no appreciable trend
regarding the location of the MI, flow in the IRA, LVEF or
time of death after the MI.
Patients excluded from the study because of “technical
failure” or persistent ST segment elevation. Patients who
were excluded because of “technical failure” or persistent ST
segment elevation had comparable demographic and coronary
risk factors profiles. In the “technical failure” group patients,
the time from the onset of symptoms to the start of thrombo-
lytic therapy was shorter (mean 2.4 vs. 3.1 h) and peak ST
segment elevation (mean 500 vs. 172 mV) and peak creatine
kinase (mean of 2,208 vs. 1,170 U/liter) were higher compared
with the patients excluded because of persistent ST segment
elevation. The in-hospital outcomes in both groups of excluded
patients were comparable.
Discussion
Controversy continues regarding the pathogenesis and clin-
ical significance of ST segment depression occuring concomi-
tantly with ST segment elevation during AMI. Existing opin-
ions about the etiology can be broadly categorized as such ST
segment depression 1) is a “reciprocal” image of the ST
segment elevation in the infarct zone (3–7); 2) signifies poste-
rior myocardial involvement in addition to the inferior infarc-
tion (8–10); 3) signifies larger, more extensive infarction
(11–14); or 4) represents additional ischemia outside the
infarct zone (15–19). The prognostic significance of such ST
segment depression as an indicator of higher risk for adverse
outcomes also continues to be debated (1–19).
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The results of our study suggest that controversy regarding
the significance of concomitantly occurring ST segment eleva-
tion and ST segment depression on a static ECG has persisted
because of the heterogeneity of this population. When ST
segment depression is studied over time relative to the reso-
lution of ST segment elevation, two broad groups are dis-
cerned: 1) those in whom ST segment depression resolves
simultaneously with ST segment elevation; and 2) those in
whom ST segment depression persists independent of ST
segment elevation resolution. When either the “reciprocal”
image of ST segment elevation or posterior extension of
inferior infarction produces ST segment depression, reperfu-
sion through the IRA would be expected to lead to simulta-
neous resolution of ST segment elevation as well as ST
segment depression. In contrast, persistent ST segment depres-
sion despite reperfusion and ST segment elevation resolution
might be the result of a very different mechanism, such as
ongoing ischemia outside the perfusion area of the IRA.
Without addressing pathophysiologic mechanisms, our data
show that the pattern of ST segment depression in the inde-
pendent group is associated with significantly higher in-
hospital mortality compared with that in the control and
simultaneous groups. This higher mortality in the independent
group occurred despite a more favorable baseline profile, as
Table 1. Baseline Characteristics
Variable
Control Group
(n 5 66)
Simultaneous Group
(n 5 165)
Independent Group
(n 5 30)
Age (yr) 60 (49, 71) 58 (51, 68) 58 (49, 67)
Male 65% 71% 70%
White 82% 87% 100%
Previous MI 6% 17% 13%
Family history of CAD 63% 56% 63%
Past or current smoker 80% 79% 83%
Diabetes mellitus 19% 21% 7%
Hypertension 52% 40% 20%
Time to Rx (h)* 3.1 (2.2, 4.2) 2.4 (1.8, 3.3) 2.5 (2.0, 3.8)
Peak ST seg elevation (mV)† 300 (176, 497) 510 (275, 725) 340 (250, 505)
Peak CK (U/liter) 1,368 (712, 3,183) 1,686 (776, 2,924) 1,348 (843, 1,864)
Anterior MI 68% 35% 13%
IRA‡ n 5 62 n 5 157 n 5 27
LAD 47% 32% 15%
RCA 35% 53% 74%
LCx 8% 13% 7%
Grafts 2% 0 0
Unknown 8% 2% 4%
LVEF (%)§ 55 (45, 62) 52 (45, 60) 54 (47, 62)
CAD n 5 62 n 5 151 n 5 26
0 VD 3% 1% 4%
1 VD 55% 55% 50%
2 VD 27% 29% 23%
3 VD 15% 15% 23%
IRA TIMI flow grade n 5 49 n 5 140 n 5 21
0 14% 14% 19%
1 2% 4% 0%
2 8% 19% 10%
3 76% 63% 71%
*Time between onset of symptoms and thrombolytic therapy administration. †Peak ST segment (seg) elevation in the
worst of the leads with ST segment elevation, during continuous 12-lead electrocardiographic monitoring. ‡Angiographi-
cally determined infarct-related artery (IRA). §Left ventricular ejection fraction (LVEF) determined by cardiac
catheterization. Data presented are percent of patients or 50th (25th, 75th) percentile. CAD 5 coronary artery disease;
CK 5 creatine kinase; LAD 5 left anterior descending coronary artery; LCx 5 left circumflex artery; MI 5 myocardial
infarction; RCA 5 right coronary artery; Rx 5 medication; TIMI 5 Thrombolysis in Myocardial Infarction; VD 5 vessel
disease.
Table 2. In-Hospital Outcomes*
Variable
Control
Group
(n 5 66)
Simultaneous
Group
(n 5 165)
Independent
Group
(n 5 30)
Mortality 0 (0–4) 1 (0–4) 13 (4–29)
Recurrent MI 2 (0–8) 2 (0–5) 3 (0–17)
Congestive heart failure 29 (18–40) 28 (21–35) 33 (16–50)
Recurrent angina 11 (5–19) 13 (8–18) 13 (4–29)
*p 5 0.002 for mortality comparison between the control group and the
independent group and p , 0.001 between the simultaneous group and the
independent group; all other outcomes were not significantly different between
groups. Data presented are percent of patients (95% confidence intervals). MI 5
myocardial infarction.
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indicated by lower incidences of diabetes mellitus, hyperten-
sion and anterior MI.
Our findings are consistent with the hypotheses suggested
in a few previous studies that have considered the possibility of
heterogeneity in patients who have concomitantly occurring ST
segment elevation and depression. In these studies patients
were grouped according to the patterns of relative resolution
of ST segment depression versus elevation over time (11,26–
29). To our knowledge, our data currently represent the largest
cohort reported with continuous 12-lead ECG monitoring, as
well as the only study in which ST segment analysis was
performed in blinded manner with regard to all other patient
data.
Study limitations. There are several notable limitations of
this study. One limitation is our inability to elucidate the
pathogenic mechanisms causing ST segment depression out-
side the leads showing ST segment elevation during MI. We
specifically examined the extent of coronary artery disease in
this cohort with the intuitive assumption that independent
persistence of ST segment depression would most frequently
represent ischemia in patients with multivessel coronary dis-
ease. Persistent dysfunction in the infarct zone, despite reper-
fusion (as indicated by the resolution of ST segment elevation),
has been associated with compensatory hyperkinesia in the
noninfarct zone. This phenomenon has been well described
(30–32). Hyperkinesia in the noninfarct zone may result in the
demand for increased perfusion. If the noninfarct zone was
supplied by compromised coronary flow, this “biologic stress
test” might be expected to produce persistent ischemic ST
segment depression independent of reperfusion-induced ST
segment elevation resolution. We and other investigators have
previously observed simultaneous patterns of ST segment
depression and elevation resolution during transient coronary
occlusion with angioplasty in patients with single-vessel coro-
nary artery disease (33,34). Thus, when observed during AMI,
we expected that this simultaneous resolution would be asso-
ciated with a single coronary lesion causing both types of ST
segment changes. In fact, our data showed no difference in the
extent of coronary artery disease between the simultaneous
and independent groups. Further studies will be required to
elucidate the pathogenic mechanisms responsible for our
observations.
All the patients included in our study received thrombolytic
therapy, so it is uncertain how these findings can be extrapo-
lated to patients with AMI in whom spontaneous reperfusion
occurs. Second, patients included in our study were originally
enrolled in ECG substudies of the TAMI-9 and GUSTO trials.
Although these trials had similar inclusion criteria, a treatment
difference could still be a potential source of bias. The
multicenteric and retrospective nature of the parent trials was
also the reason that data on the incidence of left ventricular
hypertrophy and left ventricular end-diastolic pressure could
not be collected. Information on these variables could poten-
tially be valuable in correlating patterns of ST segment reso-
lution with clinical outcomes. Third, although the baseline
characteristics profile did not project worse outcomes in the
independent group, the effect of different incidences of hyper-
tension, previous MI and other baseline characteristics on ST
segment resolution patterns in the subgroups cannot be ascer-
tained. Each of these conditions may affect the baseline ECG,
and so might contribute to possible bias in the study group
because our method was based on ST segment resolution
relative to each patient’s baseline ST segment level. Another
limitation of this method is that it is applicable only to patients
who show resolution of ST segment elevation suggesting
reperfusion. However, persistent ST segment elevation has
been shown to be an independent indicator of poor outcomes
(35–37). Finally, although ours is the largest study of its kind
reported to date, the size of our group is still relatively small.
For this reason and because of the limitations mentioned
earlier, validation of our findings in a larger prospective trial is
needed.
Table 3. Characteristics of Patients Who Died
Pt No./
Gender Group
Age
(yr)
Leads With ST
Segment Elevation
No. of
Vessels
With CAD* IRA†
IRA TIMI
Flow
Grade
LVEF
(%) Reinfarction CHF
Recurrent
Angina
Day and Cause
of Death‡
1/M S 77 II, III, aVF, V5, V6 3 RCA 3 64 Yes Yes No 32, Postoperative
2/M S 71 II, III, aVF Unknown Unknown Unknown Unknown No Yes No 21, intracranial
bleeding
3/F I 78 V1–V4, II, III, aVF 3 LAD 0 37 No Yes Yes 5, hypotension,
CHF
4/F I 80 II, III, aVF 3 RCA 3 82 No No Yes 33, ventricular
rupture
5/F I 59 II, III, aVF, I, aVL 1 RCA 3 35 Yes No No 3, Reocclusion
of IRA
6/M I 71 V1, V3, V4, I, aVL 2 LCx 0 31 No Yes No 1, papillary
muscle
rupture
*Number of major epicardial coronary arteries with $50% lumen stenosis. †Angiographically determined infarct-related artery. ‡The day of death indicates the
days after the onset of symptoms of acute myocardial infarction. CHF 5 congestive heart failure; F 5 female; I 5 independent; M 5 male; S 5 simultaneous; other
abbreviations as in Table 1.
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Clinical implications. Continuous analysis of ST segment
depression resolution relative to ST segment elevation resolu-
tion provides additional clinical information. Presuming con-
firmation of these findings, continuous analysis of ST segment
depression outside the leads showing ST segment elevation
may provide a unique method for early risk stratification of
patients with AMI.
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